Related Experiment Video

Updated: Jul 2, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Development of targeted oncolytic virotherapeutics through translational research

Ta-Chiang Liu1, Tae-Ho Hwang, John C Bell

  • 1Jennerex Biotherapeutics, One Market Street, Spear Tower, Suite 2260, San Francisco, CA 94105, USA.

Expert Opinion on Biological Therapy
|August 13, 2008
PubMed
Abstract

Insights

Oncolytic virotherapeutics show promise for cancer treatment but require further development. Integrating laboratory and clinical research is key to overcoming challenges and optimizing these therapies for patient success.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Oncolytic virotherapeutics offer a promising avenue for cancer treatment.
  • Despite their potential, the clinical success of oncolytic virotherapeutics has been limited.
  • Bridging laboratory findings with clinical application through translational research is crucial for advancement.

Purpose of the Study:

  • To identify and analyze hurdles encountered in the clinical application of oncolytic virotherapy.
  • To review advancements in translational research aimed at overcoming these challenges.
  • To discuss strategies for developing next-generation oncolytic virotherapeutics.

Main Methods:

  • Review of clinical trial data for wild-type and first-generation oncolytic viruses.
  • Analysis of virus engineering and design improvements.
  • Evaluation of translational research efforts.

Main Results:

  • Identified key challenges in clinical trials of oncolytic virotherapeutics.
  • Detailed specific virus engineering and design modifications.
  • Highlighted the impact of translational research on product optimization.

Conclusions:

  • Iterative collaboration between laboratory research and clinical practice is essential.
  • This bidirectional approach drives the optimization of oncolytic virotherapy products.
  • Successful development hinges on addressing clinical and laboratory-derived issues.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...